Amennah S. Moghaddam is a Pleasanton, California based nurse practitioner. Active license number of Amennah S. Moghaddam is 95000419 in California. Her current practice location is 4361 Railroad Ave, Pleasanton. Patients can reach her at 925-462-1755. Amennah S. Moghaddam is NP and her NPI number (Unique professional ID assigned by NPPES) is 1285046557. Amennah S. Moghaddam has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Amennah S. Moghaddam speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1285046557
NPI Enumeration Date:
21 May, 2014
NPI Last Update On:
27 Dec, 2016
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Amennah S. Moghaddam are as mentioned below.
License Number
Specialization
State
Status
95000419
California
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Amennah S. Moghaddam 4361 Railroad Ave, Pleasanton, California
Zip:
94566-6611
Phone Number:
925-462-1755
Patients can reach Amennah S. Moghaddam at 4361 Railroad Ave, Pleasanton, California or can call to book an appointment on 925-462-1755.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 October, 2024.